Medtronic Receives CE Mark Approval for SenSight™ Directional Lead System for DBS Therapy globalbankingandfinance.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalbankingandfinance.com Daily Mail and Mail on Sunday newspapers.
Newronika Announces CE Mark Approval for AlphaDBS™ System for Parkinson s Disease
News provided by
Share this article
Share this article
MILAN, Feb. 23, 2021 /PRNewswire/ Newronika, a spin-off of the world-class neurological research center Policlinico of Milan and University of Milan, announced today it received CE Mark approval for its AlphaDBS System.
AlphaDBS is the first rechargeable deep brain neurostimulation system that can continuously record and interpret bioelectrical neuronal activity in the brain areas where stimulation is delivered. AlphaDBS s proprietary sensing technology records noise-free local field potentials while electrical stimulation is delivered. The AlphaDBS system is also capable of closed-loop stimulation in which the current delivered is automatically adjusted for the individual needs of each patient, a true revolution in DBS care and personalized medicine. This feature is currently under clinical evaluation. When available, it will be the mo
Newronika Announces CE Mark Approval for AlphaDBS™ System for Parkinson s Disease prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.